Co-Authors
This is a "connection" page, showing publications co-authored by Giuseppe Biondi-Zoccai and Enrico Cerrato.
Connection Strength
0.764
-
Safety of intermediate left main stenosis revascularization deferral based on fractional flow reserve and intravascular ultrasound: A systematic review and meta-regression including 908 deferred left main stenosis from 12 studies. Int J Cardiol. 2018 Nov 15; 271:42-48.
Score: 0.199
-
What is the optimal treatment for symptomatic patients with isolated coronary myocardial bridge? A systematic review and pooled analysis. J Cardiovasc Med (Hagerstown). 2017 Oct; 18(10):758-770.
Score: 0.184
-
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart. Clin Exp Med. 2021 May; 21(2):249-268.
Score: 0.058
-
Corrigendum to "Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study" [Int. J. Cardiol. 250 (2018) 80-85]. Int J Cardiol. 2018 07 15; 263:188.
Score: 0.049
-
Unprotected Left Main Coronary Artery Disease: Outcomes of Treatment With Second-Generation Drug-Eluting Stents - Insight From the FAILS-2 Study. J Invasive Cardiol. 2018 08; 30(8):283-288.
Score: 0.048
-
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trial. Int J Cardiol. 2018 04 15; 257:1-6.
Score: 0.048
-
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study. Int J Cardiol. 2018 Jan 01; 250:80-85.
Score: 0.046
-
Optical coherence tomography compared with fractional flow reserve guided approach in acute coronary syndromes: A propensity matched analysis. Int J Cardiol. 2017 Oct 01; 244:54-58.
Score: 0.045
-
Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents. Am J Cardiol. 2017 07 01; 120(1):33-39.
Score: 0.044
-
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study). Am J Cardiol. 2017 Apr 01; 119(7):978-982.
Score: 0.044